This message was sent to ##Email##
CALL FOR PAPERS – Submission Portal Closes on Sept. 5
Symposia and Ignite Symposia, Workshops, Roundtables, New Research Poster Sessions, and Awards
The 2020 ADAA Conference Committee invites you to submit your presentations for the 40th Annual Conference to be held in San Antonio, TX (March 19-22, 2020) at the San Antonio Marriott Rivercenter.
The 2020 Conference committee is co-chaired by Cindy J. Aaronson, PhD, and Adriana Feder, MD. Visit the ADAA website for #ADAA2020 submission and #ADAA2020 program updates. Please also view the "How to Submit" Guidelines.
- Any submissions pertaining to the diagnosis, treatment, and/or prevention of depression related disorders
- Interactive presentations comprised of both clinicians and researchers and speakers from different institutions.
- Submissions on diversity and those related to cultural, racial, and socioeconomic barriers to mental health care.
Save up to $100 on registration fees with our Early Bird Rates!
Special member doctoral level professional rate of $450 and master’s level rate of $425 – only valid until Dec. 1, 2019.
#ADAA2020 Hotel Information
The San Antonio Marriott Rivercenter - #ADAA2020 Conference Hotel
The 2020 Anxiety and Depression Conference (March 19-22) will be held at the San Antonio Marriott Rivercenter (101 Bowie Street, San Antonio, TX 78205) on the San Antonio River. Conference activities including all sessions, exhibits, and receptions take place at the San Antonio Marriott Rivercenter, which will be newly renovated in February.
Special ADAA Rate: $229 Single/Double
Please reserve your room prior to February 24, 2020
La Quinta San Antonio Riverwalk
La Quinta is located directly across the street from the headquarters hotel and a one-minute walk to the conference rooms at the Marriott Rivercenter. It includes a complimentary breakfast for overnight guests.
Special ADAA Rate: $199 Single/Double
Please reserve your room prior to February 24, 2020
Keynote Address and Opening Session
Resilience in Science and Practice: Pathways to the Future
Thursday, March 18
In the #ADAA2020 Keynote Address, Dr. Masten will highlight the alignment of findings in research on resilience in individuals, families, and communities, and the implications of a systems model for practice and policy. Exciting new horizons for integrated research and practice that bridge levels of analysis, systems, and disciplines will be discussed. Read more about the keynote address here.
The #ADAA2020 Scientific Research Symposium
The Scientific Research Symposium features leaders in the fields of psychiatry, psychology, and neuroscience. This year’s symposium features:
Learn more about the SRS topics and Register for #ADAA2020.
- Scott Russo, PhD, Professor of Neuroscience and Psychiatry, Mount Sinai School of Medicine
- Tallie Baram, MD, PhD, Danette Shepard Professor of Neurological Sciences, Director, Conte Center at UCI, University of California, Irvine
- Nim Tottenham, PhD, Associate Professor of Psychology, Columbia University
- Michelle G. Craske, PhD, Distinguished Professor, Director, Anxiety & Depression Research Center; UCLA Department of Psychology and Department of Psychiatry & Biobehavioral Sciences, ADAA Member
Apply for an #ADAA2020 Award Today!
Since its inception, the ADAA awards program (through the Alies Muskin Career Development Leadership Program and the Donald F. Klein Early Career Investigator Award) has awarded more than one million dollars to 400+ aspiring professionals and provide them with access to a professional home, unique pairings with senior mentors from our membership, and participation at the 2020 Annual Conference (March 19-22 in San Antonio, Texas). The ADAA Awards application deadline is Oct. 1, 2019.
Thank you to our Current #ADAA2020 Sponsors
Thank you to our Current #ADAA2020 Exhibitors
Lido Wellness Center
Renewed Freedom Center
Donald F. Klein, MD, DSc
Last week the world lost a dominant figure in the psychiatric field and a longtime ADAA friend. Donald F. Klein, MD (1928-2019) revolutionized psychiatric thinking through his discovery in the early 1960s that imipramine, a recently developed psychotropic medication, was effective in blocking panic attacks. Dr. Klein’s early contribution to the development of the DSM in large part gave birth to the modern branch of medical science dealing with the classification of disease of anxiety disorders. His early findings also heralded in the era of childhood anxiety disorders as biochemical disorders when he discovered that imipramine blocked childhood separation anxiety disorders.
In later years, Dr. Klein developed a compelling evolutionary-based hypothesis accounting for the etiology of panic disorders, which he terms “the false suffocation alarm theory of panic disorders.” His work remains relevant and topical to the present. Dr. Klein was an active member, mentor, supporter and champion of ADAA’s work and mission. He was the recipient of the 2005 ADAA Lifetime Achievement Award and his work and accomplishments live on in the Donald F. Klein Early Investigator Award, which is presented at ADAA’s annual conference to an early career investigator for the best original research paper on neurobiology, psychopharmacology, psychosocial treatments, or experimental psychopathology of anxiety disorders and depression.
ADAA member Philip R. Muskin, MD, MA, DLFAPA, Professor of Psychiatry and Senior Consultant, Columbia University shares this personal tribute.
“Last week Dr. Donald Klein passed away. He was just shy of his 91st birthday. I write this in memoriam of a mentor to whom I am forever grateful. Don is known for many core accomplishments as a researcher. He coined the term panic disorder and pioneered the use of tricyclic antidepressants in the treatment of the disorder. He and colleagues explored concepts of what caused panic disorder. This was most certainly not his only accomplishment as a master psychopharmacologist and researcher; there are many more.
I met Don as a PGY-3 resident at the NYS Psychiatric Institute. He was the lead of the “Quitkin, Rifkin, and Klein” group of psychiatric researchers brought to the institution by Edward Sachar. Sadly, that entire esteemed group has passed on. Don was working on panic disorder, using sodium lactate and then CO2 to induce panic attacks in subjects. He, Abby Fyer, and I submitted a protocol to use desipramine to treat panic disorder. Abby and I were the psychotherapists for the patient, doing psychotherapy plus psychopharmacology in an open label study. Don supervised us. Supervision with Don was an amazing experience. He had file cabinets filled with patient records that he would consult when we talked about various patients. It truly seemed that no patient presentation we would discuss was not a patient presentation he had not seen before. His supervision was always broad, and for someone who was alleged to be “anti-psychoanalytic” publicly, that was certainly not the case during supervision.
Let me detail two personal interactions I had with Don that I hope will reveal what it was like to know him and work with him. After the research was complete, Abby and I wrote it up to submit a paper. Each version was sent to Don for editing. The paper would come back filled with red ink. Each time he would say, “Put it in a drawer for a week or so. Take it out and read it as if it was written by someone else.” After many revisions we sent him the manuscript we were ready to submit, with the names Muskin, Fyer, and Klein as authors. He sent it back with a note (in red): “Why is my name on the paper? I didn’t do the study.” Amazingly, the paper was accepted without revisions. Don kindly said to me, “Enjoy this, as it will never happen again.” How true was that advice!
The second was a teaching session with the residents at NYS Psychiatric Institute. Don and I were teaching about depression, using Mourning and Melancholia to discuss depression. I was a fellow and a psychoanalytic candidate, so it made some sense that I was part of the team. For someone “anti-psychoanalytic,” it was clear Don had studied Freud carefully. We each had our volume of the Collected Works with us. Mine was pristine, the pale blue book jacket intact, the pages with a bit of wear from reading, but otherwise clean. Don’s book had a torn book jacket; the pages were filled with notes over every open space. There were arrows pointing from one note to the next. This was a volume that had been read, re-read, thought about, and thought about again. Don offered no critique of Freud absent that he felt the patients discussed had psychotic depression. He did not disagree; it was his diagnostic observation.
There was never a time, even after I left Don’s research group, that he did not take a call from me for clinical supervision. We chatted often, including when he referred patients to me. When he would tell me about an extremely psychotic patient he wanted me to see and I would discuss which antipsychotic to start with, he would always remind me, “You have to talk to the patient first, Phil.”
That is the Don Klein I will always remember. The personal Don, someone who changed the way we think about and treat patients.”
ADAA Member Benefit Alert!
Did you know? ADAA offers free subscriptions to our online research journal Depression and Anxiety to members. Learn more here.
ADAA Member News
ADAA Past President Karen Cassiday, PhD, ACT has been volunteering in Bhutan with Health Volunteers Overseas (HVO) in the Department of Psychiatry at the Jigme Dorji Wanchuck National Referral Hospital in Bhutan over the past few months and shares an August update of her trip.
New ADAA Member Public Blog Posts
So You've Decided to Start Therapy for Your Anxiety…Here's How to Make It Work
by Michael Stein, PsyD
Have you been quoted in a recent news article/story? Please let us know so we can share your news with your ADAA colleagues and with our public community (here, through the website and via our social media platforms).
08/08/2019 Researchers Test Feasibility of a Blood Test to Gauge PTSD Risk Immediately Following Trauma, BBRF, Charles Nemeroff, MD, PhD, Kerry Ressler, MD, PhD, Barbara Rothbaum, PhD
08/05/2019 Defining Resilience: The US Army and Mindfulness, Thrive Global, Martin Paulus, MD
08/05/2019 How To Stop August Anxiety Before It Even Begins, Refinery 29, Debra Kissen, PhD, MHSA
08/01/2019 Do Therapy Apps Work?, Menshealth, Steven Chan, MD, PhD
07/31/2019 Ketamine Isn't an Opioid and Treats Depression in a Unique Way, Science Daily, Adam Kaplin, MD, PhD
07/30/2019 Anxiety Looks Different in Men, WSJ, Kevin Chapman, PhD, Dean McKay, PhD, and Douglas Mennin, PhD
07/29/2019 How ‘Anxiety Disorders’ Trick Us, Psychotherapy Excellence, David Carbonell, PhD
Member Publications and Research News
Have you published a new book for consumers or professionals? Please let us know so we can highlight your new publication here and on the ADAA website.
ADAA is also interested in highlighting our members' research. Please send us your recent research news for us to post and share.
- ADAA member Reid Wilson offers a new, free video on OCD self-help entitled “8 Self-Help Principles in 5 Minutes.”
Foundations provides an efficient admissions process and works to meet the patient where they are to get them the help they need. To help with referrals, we provide in-network contracts, an easy assessment and placement process and the ability to place patients that have no resources or transportation. Learn more about our treatment methods, evidence-based outcomes, and credentials.
We Love Our Facebook Fundraisers
ADAA would like to extend a huge thank you to those who choose to fundraise on behalf of ADAA - your generosity makes a critical difference. You and your Facebook friends can support causes that are important to you (like ADAA) by raising funds and awareness right on Facebook.
Read more and start your own fundraiser today.
Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to the charity of your choice. AmazonSmile is the same Amazon you know. Same products, same prices, same service. Select ADAA on AmazonSmile and support our work with every item you purchase. Shop today.
Shop ADAA’s Merchandise
Buy a gift for yourself and a loved one and support ADAA at the same time. Proceeds support ADAA's mission to provide free resources to those struggling with anxiety, depression and co-occurring disorders. Shop ADAA's Store.
ADAA offers a variety of webinars for mental health professionals. Most ADAA professional webinars offer CE/CME and AWSB credits.
Thursday, September 12, 2019 — Michael Ziffra, MD presents:
Coexisting Anxiety and ADHD: Addressing Challenges in Diagnosis and Treatment
Eligible for 1 CE/CME hour
Thursday, September 26, 2019 - Katherine Shear, MD presents:
Complicated Grief and Its Treatment
Eligible for 1 CE/CME credit
Just Announced! Fall 2019 Live Interactive Forum - Wednesday, October 30th, 12:00pm - 4:00pm ET
Featuring Kimberly Yonkers, MD, Margaret Altemus, MD, Catherine Monk, PhD and Rahil Briggs, PhD. Registration now open.
Spotlight on Maternal Mental Health: Treatment and Research
Eligible for 3 CE/CME credits
Interested in presenting a professional webinar? Click here to download the ADAA Webinar Interest Form or contact Astrid Masfar (email@example.com)
Volume 36, Issue 7
FOCUS ON: The Impact of Trauma on Mental Health: PTSD and Beyond
Association between early‐life trauma and obsessive compulsive symptoms in community youth
Ran Barzilay, Ariana Patrick, Monica E. Calkins, Tyler M. Moore, Ruben C. Gur, Raquel E. Gur
Association between posttraumatic stress disorder severity and amygdala habituation to fearful stimuli
Ye Ji Kim, Sanne J.H. van Rooi, Timothy D. Ely, Negar Fani (ADAA Member), Kerry J. Ressler (ADAA Member), Tanja Jovanovic (ADAA Board Member), Jennifer S. Stevens (ADAA Member)
Not just in Philadelphia – But across the globe
James F. Leckman, Joanna Rubinstein
Depression and Anxiety in the News
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online at no charge to ADAA members. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans. Per the ISI Journal Citation Reports Rankings for 2017, the Depression and Anxiety impact factor is 5.043. The journal ranks 19 of 142 in psychiatry journals; 8 of 77 in psychology journals; 5 of 121 for psychology clinical journals, and 15 of 139 for psychiatry social science journals. Google Scholar psychiatry journal ranking (spring 2017) ranked Depression and Anxiety #19 of 20.
Murray B. Stein, MD, MPH - Editor-in-Chief
Meet the Journal Editorial Board
Interested in submitting an article? View the Depression and Anxiety Submissions Guidelines.
Pecori is excited to announce that the Patient-Centered Outcomes Research Institute (PCORI) will be updating the Research Areas of Interest within the Broad PCORI Funding Announcement for Cycle 3 2019, calling out the following topics:
Pecori invites you to review this pre-announcement, available on their website, and share this information with others who may be interested. Register for the town hall on Wednesday, September 25 at noon ET. The funding announcement will be released on September 3, 2019.
- Dosing of anti-neoplastic agents in adults
- Genetic sequencing to guide cancer treatment
- Peripheral artery disease
- Suicide prevention
| || RESEARCH AND PRACTICE NEWS|
As the tragic news of mass shootings in El Paso, Texas, and Dayton, Ohio, dominates the news cycle, Americans confront a rising sense of unease. Sources of the anxiety include issues like white supremacy, gun control, terrorism and the way our society views mental illness.
But there’s also a personal mental health component. A recent BuzzFeed report described a “new kind of anxiety and fear” in our era ― a feeling that wherever you go, you might be making yourself unsafe and vulnerable to a mass attack. This is a natural response to highly publicized traumatic events.
Last year, the American Psychological Association published an analysis of more than 200 studies focusing on some 90,000 adolescents. It found that Latino youth have higher levels of depression than their white and African American peers in response to discrimination. The researchers linked it to being viewed as perpetual foreigners. For Latino youths in the U.S., the El Paso shooting is just the latest trauma.
Like clockwork, mental illness has become the focal point for blame following America’s 255th mass shooting this year.
“Mental illness and hatred pulled the trigger, not the gun,” President Donald Trump said in a televised statement after two mass shootings took the lives of at least 30 over the weekend of Aug. 3. But people with mental illnesses are 10 times more likely to be victims of violent crimes, and only three percent to five percent of violent crimes can be linked to mental illnesses, according to national statistics.
Results from a meta-analysis published in Pediatrics demonstrated the efficacy of universally delivered interventions in improving adolescent mental health and reducing risk behavior. In addition, the following three treatment components emerged as consistently effective across outcomes: interpersonal skills, emotion regulation, and alcohol and drug education.
The lifetime prevalence of a substance use disorder hovers around 20 percent in the general population. The lifetime prevalence of chronic pain is about the same.
Rates of both are much higher, however, in the psychiatric patient population.
“The overlap of these two disorders with other major psychiatric disorders such as depression, psychosis (schizophrenia), and post-traumatic stress disorder is substantial,” said Thomas R. Kosten, MD, professor of psychiatry, pharmacology, and neuroscience at Baylor College of Medicine in Houston, Texas. “Eighty percent of patients with schizophrenia and 35 percent of patients with major depression smoke. For alcohol and marijuana, the rates are also high, with about 20 to 30 percent of patients with major psychiatric disorders also having these SUDs.”
“Thus, having either a SUD or chronic pain—and often, both—occurs in about half of patients with major psychiatric disorders.”
June Tangney of George Mason University has studied shame for decades. In numerous collaborations with Ronda L. Dearing of the University of Houston and others, she has found that people who have a propensity for feeling shame—a trait termed shame-proneness—often have low self-esteem (which means, conversely, that a certain degree of self-esteem may protect us from excessive feelings of shame). Tangney and Dearing are among the investigators who have found that shame-proneness can also increase one’s risk for other psychological problems. The link with depression is particularly strong; for instance, one large-scale meta-analysis in which researchers examined 108 studies involving more than 22,000 subjects showed a clear connection.
Internet-delivered treatment providing psychological intervention for mental health needs for college students may provide good clinical outcomes in an acceptable format, according to a study published in the Journal of Affective Disorders.
World Economic Forum
Depression affects 300 million people across the globe and is the leading cause of disability worldwide according to the World Health Organization. It costs the global economy $1 trillion every year, but fewer than half of those affected receive any treatment.
So Denmark is trying a different approach: People suffering from depression are encouraged to take part in cultural activities. They call it Kulturvitaminer – “culture vitamins” – and it is being trialled in four cities.
New research suggests that babies born during autumn and winter are at increased risk of developing mental health disorders, as mothers giving birth during these seasons have higher levels of the stress-related hormone cortisol.
The study, which is the first to report results on the effects of the seasons on maternal salivary cortisol levels in late pregnancy, investigated the links between seasonality and the risk of children developing anxiety or depression in later life.
Lower cardiorespiratory fitness levels were linked to a higher risk for depression and anxiety disorders, according to findings from a systematic review and meta-analysis published in Journal of Affective Disorders.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063